Mesoblast
MESO
51 hedge funds and large institutions have $61.1M invested in Mesoblast in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 8 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
90% more capital invested
Capital invested by funds: $32.1M → $61.1M (+$29M)
19% more funds holding
Funds holding: 43 → 51 (+8)
0.03% more ownership
Funds ownership: 0.25% → 0.28% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
80% less call options, than puts
Call options by funds: $12.2M | Put options by funds: $61.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.74M |
| 2 |
CAC
Cowen and Company
New York
|
+$4.07M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.71M |
| 4 |
TM
Tikvah Management
Charlotte,
North Carolina
|
+$2.25M |
| 5 |
JP Morgan Chase
New York
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MGIM
M&G Investment Management
London,
United Kingdom
|
-$9.38M |
| 2 |
Goldman Sachs
New York
|
-$2.65M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$808K |
| 4 |
Millennium Management
New York
|
-$619K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$206K |
MESO Hedge Fund Activity: Q3 2020 in Review
51 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2020, worth a combined $61.1M — up 90% from $32.1M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new MESO positions and 8 closed out — a net gain of 8 holders — while 19 added to existing stakes and 8 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $5.74M. The largest seller was M&G Investment Management, cutting an estimated $9.38M.
- 51 institutional investors held Mesoblast (MESO) as of Q3 2020, up from 43 in Q2 2020.
- Funds reported $61.1M of Mesoblast stock for Q3 2020, up 90% quarter-over-quarter.
- 16 funds opened new Mesoblast positions in Q3 2020 and 8 closed out, a net change of +8 holders.
- The largest Mesoblast buyer in Q3 2020 was Susquehanna International Group, an estimated $5.74M added.
- The largest Mesoblast seller in Q3 2020 was M&G Investment Management, an estimated $9.38M sold.
Based on aggregated 13F filings for Q3 2020.